Literature DB >> 21518167

Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions.

Toine ten Broeke1, Guillaume van Niel, Marca H M Wauben, Richard Wubbolts, Willem Stoorvogel.   

Abstract

Major histocompatibility complex (MHC) class II (MHCII) is constitutively expressed by immature dendritic cells (DC), but has a short half-life as a consequence of its transport to and degradation in lysosomes. For its transfer to lysosomes, MHCII is actively sorted to the intraluminal vesicles (ILV) of multivesicular bodies (MVB), a process driven by its ubiquitination. ILV have, besides their role as an intermediate compartment in lysosomal transfer, also been proposed to function as a site for MHCII antigen loading and temporal storage. In that scenario, DC would recruit antigen-loaded MHCII to the cell surface in response to a maturation stimulus by allowing ILV to fuse back with the MVB delimiting membrane. Other studies, however, explained the increase in cell surface expression during DC maturation by transient upregulation of MHCII synthesis and reduced sorting of newly synthesized MHCII to lysosomes. Here, we have characterized the relative contributions from the biosynthetic and endocytic pathways and found that the vast majority of antigen-loaded MHCII that is stably expressed at the plasma membrane by mature DC is synthesized after exposure to inflammatory stimuli. Pre-existing endosomal MHCII contributed only when it was not yet sorted to ILV at the moment of DC activation. Together with previous records, our current data are consistent with a model in which passage of MHCII through ILV is not required for antigen loading in maturing DC and in which sorting to ILV in immature DC provides a one-way ticket for lysosomal degradation.
© 2011 John Wiley & Sons A/S.

Mesh:

Substances:

Year:  2011        PMID: 21518167     DOI: 10.1111/j.1600-0854.2011.01212.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  9 in total

Review 1.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 2.  The ins and outs of MHC class II-mediated antigen processing and presentation.

Authors:  Paul A Roche; Kazuyuki Furuta
Journal:  Nat Rev Immunol       Date:  2015-02-27       Impact factor: 53.106

Review 3.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

Review 4.  Co-ordination of incoming and outgoing traffic in antigen-presenting cells by pattern recognition receptors and T cells.

Authors:  Priyanka Nair; Derk Amsen; J Magarian Blander
Journal:  Traffic       Date:  2011-08-15       Impact factor: 6.215

5.  Quantitating MHC class II trafficking in primary dendritic cells using imaging flow cytometry.

Authors:  Cassandra M Hennies; Maria A Lehn; Edith M Janssen
Journal:  J Immunol Methods       Date:  2015-05-09       Impact factor: 2.303

6.  Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation.

Authors:  Bryan Vander Lugt; Aly A Khan; Jason A Hackney; Smita Agrawal; Justin Lesch; Meijuan Zhou; Wyne P Lee; Summer Park; Min Xu; Jason DeVoss; Chauncey J Spooner; Cecile Chalouni; Lelia Delamarre; Ira Mellman; Harinder Singh
Journal:  Nat Immunol       Date:  2013-12-22       Impact factor: 25.606

Review 7.  Presentation of phagocytosed antigens by MHC class I and II.

Authors:  Adriana R Mantegazza; Joao G Magalhaes; Sebastian Amigorena; Michael S Marks
Journal:  Traffic       Date:  2012-11-29       Impact factor: 6.215

8.  CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.

Authors:  Vera Rocha-Perugini; Gloria Martínez Del Hoyo; José María González-Granado; Marta Ramírez-Huesca; Virginia Zorita; Eric Rubinstein; Claude Boucheix; Francisco Sánchez-Madrid
Journal:  Mol Cell Biol       Date:  2017-07-14       Impact factor: 4.272

Review 9.  The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Edward J Filippone
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.